|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Histamine ELISA | Anti-Ustekinumab (Stelara®) ELISA | Metanephrine/Normetanephrine ELISA Assay | sAPP Beta-w (Highly Sensitive) ELISA Assay | T4 (Free) ELISA Assay |
| Citations | | | | | |
| Catalog Number | IB89128R | TM09036 | IB89186 | 27732 | IB19106 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme Immunoassay for the determination of Histamine in plasma and urine. In combination with the supplementary kit (IB89145), the assay is performed for the histamine release in heparinized whole blood. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Enzyme immunoassay (ELISA) for the determination of Metanephrine and Normetanephrine in urine. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination human sAPPß-w in EDTA plasma, cerebrospinal fluids and cell culture supernatant. For research use only, not for use in diagnostic procedures. | Solid phase competitive enzyme immunoassay (ELISA) for the determination of free Thyroxine (fT4) in human serum. For research use only, not for use in diagnostic procedures. |
| Detection Target | Histamine | sAPP Total | GHBP | Bordetella pertussis IgM | T4 (Free) |
| Sample Type | Plasma and urine. Whole blood may be used with supplementary Histamine (Release) kit, catalog # IB89145. Please see protocol for more information. | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum, Blood Plasma | Serum, Blood Plasma | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 0.5 - 50 ng/mL | Anti-Ustekinumab (Stelara®) | Metanephrine: 20 to 2000 ng/mL; Normetanephrine: 30 to 3000 ng/mL | 0.78 to 50 ng/mL | 0.45 to 7.70 ng/dL |
| Sensitivity | Plasma: 0.12 ng/mL; Urine: 0.30 ng/mL. | 0.06 ng/mL | 0.006 ng/mL | 89.19 % (95% confidence interval: 74.58% - 96.97%) | Inquire |
| Assay Time | 45 min. incubation (RT) + 15 min. (RT) + 3 hours (RT) + 30 min. (RT) + 30 min. (RT) = 5 hours total incubation time. | 2 hour, 30 min. total incubation time. | 1 hr 45 mins (incubation) | Overnight + 1 hr (incubation) | 1 hr 15 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |